Patents by Inventor Scott Schaus

Scott Schaus has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210081853
    Abstract: Embodiments of a transit ticket system are provided. The transit ticket system may include a mobile computing device configured to (i) download a mobile ticketing application from a ticket management server, the mobile ticketing application including a graphical data sheet, a ticket dictionary, and ticket strings, (ii) receive ticket rendering instructions from the ticket management server in response to completion of a ticket purchase process via the mobile computing device, and (iii) render for display an active ticket on the mobile computing device with data stored on the mobile computing device based on the ticket rendering instructions, the graphical data sheet, ticket dictionary, and ticket strings in response to an activation input command.
    Type: Application
    Filed: November 30, 2020
    Publication date: March 18, 2021
    Applicant: moovel North America, LLC
    Inventors: Nathaniel Parker, Michael L. Gray, Matthew S. Rotter, Isaac Elliott, Zachary Babb, Kurt Griffith, Alex Peter, Scott Schaus
  • Patent number: 10392398
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III?) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: August 27, 2019
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Patent number: 10314810
    Abstract: Provided herein are novel agents that modulate AhR activity for use in therapeutic compositions and methods thereof for inhibiting cancer cell proliferation and tumor cell invasion and metastasis. The agents comprise AhR inhibitors or non-constitutive AhR agonists of Formula (I) and (II) for the inhibition of cancer cell growth and parameters that characterize tumor metastasis, such as tumor cell invasiveness.
    Type: Grant
    Filed: July 27, 2011
    Date of Patent: June 11, 2019
    Assignees: Trustees of Boston University, Northeastern University, Boston Medical Center Corporation
    Inventors: David H. Sherr, Michael Pollastri, Jennifer Schlezinger, Sarah Haigh Molina, Scott Schaus, Joshua Robert Giguere
  • Patent number: 10258600
    Abstract: Provided herein are novel agents that modulate AhR activity for use in therapeutic compositions and methods thereof for inhibiting cancer cell proliferation and tumor cell invasion and metastasis. The agents comprise AhR inhibitors or non-constitutive AhR agonists of Formula (I) and (II) for the inhibition of cancer cell growth and parameters that characterize tumor metastasis, such as tumor cell invasiveness.
    Type: Grant
    Filed: March 3, 2016
    Date of Patent: April 16, 2019
    Assignees: Trustees of Boston University, Boston Medical Center, Northeastern University
    Inventors: David H. Sherr, Michael Pollastri, Jennifer Schlezinger, Sarah Haigh Molina, Scott Schaus, Joshua Robert Giguere
  • Publication number: 20180114149
    Abstract: Embodiments of a transit ticket system are provided. The transit ticket system may include a mobile computing device configured to (i) download a mobile ticketing application from a ticket management server, the mobile ticketing application including a graphical data sheet, a ticket dictionary, and ticket strings, (ii) receive ticket rendering instructions from the ticket management server in response to completion of a ticket purchase process via the mobile computing device, and (iii) render for display an active ticket on the mobile computing device with data stored on the mobile computing device based on the ticket rendering instructions, the graphical data sheet, ticket dictionary, and ticket strings in response to an activation input command.
    Type: Application
    Filed: December 20, 2017
    Publication date: April 26, 2018
    Inventors: Nathaniel Parker, Michael L. Gray, Matthew S. Rotter, Isaac Elliott, Zachary Babb, Kurt Griffith, Alex Peter, Scott Schaus
  • Publication number: 20180051033
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III?) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Application
    Filed: September 25, 2017
    Publication date: February 22, 2018
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Patent number: 9815845
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III?) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: November 14, 2017
    Assignee: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Patent number: 9802948
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III?) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: October 31, 2017
    Assignee: TRUSTEES OF BOSTON UNIVERISTY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Patent number: 9792604
    Abstract: Systems and methods for interaction-based validation of electronic tickets. In some embodiments, the system renders a first visually illustrative scene on an interactive display screen of a mobile device, the first visually illustrative scene responsive to a pre-determined gesture performed at a predetermined location on the interactive display screen. Upon a user interacting with the first visually illustrative scene, an app on the user's mobile device extracts user interaction information. In response to determining that the user interaction information matches with a predetermined gesture performed at the predetermined location, the system renders a second visually illustrative scene on the interactive display screen of the mobile device.
    Type: Grant
    Filed: December 19, 2014
    Date of Patent: October 17, 2017
    Assignee: moovel North Americ, LLC
    Inventors: Michael Gray, Nathaniel Parker, Zachary Babb, Alexandra Peter, Scott Schaus
  • Publication number: 20170107227
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III?) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 20, 2017
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Patent number: 9597325
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formulas (I)-(XXVI) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Grant
    Filed: September 30, 2011
    Date of Patent: March 21, 2017
    Assignee: Trustees of Boston University
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Publication number: 20170044175
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formula (I)-(XXVI) and (III?) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Application
    Filed: October 28, 2016
    Publication date: February 16, 2017
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Publication number: 20160175278
    Abstract: Provided herein are novel agents that modulate AhR activity for use in therapeutic compositions and methods thereof for inhibiting cancer cell proliferation and tumor cell invasion and metastasis. The agents comprise AhR inhibitors or non-constitutive AhR agonists of Formula (I) and (II) for the inhibition of cancer cell growth and parameters that characterize tumor metastasis, such as tumor cell invasiveness.
    Type: Application
    Filed: March 3, 2016
    Publication date: June 23, 2016
    Applicants: Trustees of Boston University, Northeastern University, Boston Medical Center Corporation
    Inventors: David H. SHERR, Michael POLLASTRI, Jennifer SCHLEZINGER, Sarah HAIGH MOLINA, Scott SCHAUS, Joshua Robert GIGUERE
  • Publication number: 20160180326
    Abstract: Systems and methods for interaction-based validation of electronic tickets. In some embodiments, the system renders a first visually illustrative scene on an interactive display screen of a mobile device, the first visually illustrative scene responsive to a pre-determined gesture performed at a predetermined location on the interactive display screen. Upon a user interacting with the first visually illustrative scene, an app on the user's mobile device extracts user interaction information. In response to determining that the user interaction information matches with a predetermined gesture performed at the predetermined location, the system renders a second visually illustrative scene on the interactive display screen of the mobile device.
    Type: Application
    Filed: December 19, 2014
    Publication date: June 23, 2016
    Inventors: Michael Gray, Nathaniel Parker, Zachary Babb, Alexandra Peter, Scott Schaus
  • Publication number: 20160086228
    Abstract: Systems and methods for associating and delivering context-aware content to mobile devices via a programmable trigger that is based upon changes in the mobile device's location. A user's mobile device can interact with trigger-based tracking devices (e.g., Bluetooth beacons, NFC, etc.) which provides location information to the user's mobile device, such location information being relative to the tracking device. Embodiments of the present disclosure also comprise a server that delivers targeted content (e.g., text, graphics, audio, video, etc.) to mobile devices when a user is at a certain geographical location. The content delivered is associated with a context of the user's location which is based in part on the location information received relative to the tracking device. In some embodiments, the content delivery does not require a separate mobile application for the content provider but can be embedded inside transit-related information of a mobile application of a transit agency.
    Type: Application
    Filed: September 22, 2015
    Publication date: March 24, 2016
    Inventors: Zachary Babb, Matthew Rotter, Michael Gray, Alexandra Peter, Nathaniel Parker, Scott Schaus
  • Publication number: 20130324570
    Abstract: The present invention is directed to methods, compositions and kits for treatment of cancer, e.g. heptacellular carcinoma. In some embodiments, the present invention discloses the use of a small-molecule compound of formulas (I)-(XXVI) as disclosed herein to inhibit transcription factor Late SV40 Factor (LSF) for treatment of cancer, e.g., HCC.
    Type: Application
    Filed: September 30, 2011
    Publication date: December 5, 2013
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Ulla Hansen, Scott Schaus, Trevor Grant, Joshua Bishop, John Kavouris, Lisa M. Christadore
  • Publication number: 20130281525
    Abstract: Provided herein are novel agents that modulate AhR activity for use in therapeutic compositions and methods thereof for inhibiting cancer cell proliferation and tumor cell invasion and metastasis. The agents comprise AhR inhibitors or non-constitutive AhR agonists of Formula (I) and (II) for the inhibition of cancer cell growth and parameters that characterize tumor metastasis, such as tumor cell invasiveness.
    Type: Application
    Filed: July 27, 2011
    Publication date: October 24, 2013
    Applicants: TRUSTEES OF BOSTON UNIVERSITY, BOSTON MEDICAL CENTER CORPORATION, NORTHEASTERN UNIVERSITY
    Inventors: David H. Sherr, Michael Pollastri, Jennifer Schlezinger, Sarah Haigh Molina, Scott Schaus, Joshua Robert Giguere